BNXTF
Price
$0.63
Change
-$0.02 (-3.08%)
Updated
Sep 24 closing price
Capitalization
75.47M
SNOA
Price
$4.06
Change
-$0.02 (-0.49%)
Updated
Sep 25 closing price
Capitalization
6.67M
Interact to see
Advertisement

BNXTF vs SNOA

Header iconBNXTF vs SNOA Comparison
Open Charts BNXTF vs SNOABanner chart's image
BIONXT SOLUTIONS
Price$0.63
Change-$0.02 (-3.08%)
Volume$100
Capitalization75.47M
Sonoma Pharmaceuticals
Price$4.06
Change-$0.02 (-0.49%)
Volume$15.77K
Capitalization6.67M
BNXTF vs SNOA Comparison Chart in %
Loading...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. SNOA commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and SNOA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BNXTF: $0.63 vs. SNOA: $4.06)
Brand notoriety: BNXTF and SNOA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 2% vs. SNOA: 1%
Market capitalization -- BNXTF: $75.47M vs. SNOA: $6.67M
BNXTF [@Pharmaceuticals: Generic] is valued at $75.47M. SNOA’s [@Pharmaceuticals: Generic] market capitalization is $6.67M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 4 TA indicator(s) are bullish while SNOA’s TA Score has 2 bullish TA indicator(s).

  • BNXTF’s TA Score: 4 bullish, 5 bearish.
  • SNOA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BNXTF is a better buy in the short-term than SNOA.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а +10.06% price change this week, while SNOA (@Pharmaceuticals: Generic) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNXTF($75.5M) has a higher market cap than SNOA($6.67M). BNXTF YTD gains are higher at: 151.846 vs. SNOA (50.929). SNOA has higher annual earnings (EBITDA): -3.5M vs. BNXTF (-4.93M). SNOA has more cash in the bank: 3.61M vs. BNXTF (4.24K). SNOA has less debt than BNXTF: SNOA (675K) vs BNXTF (7.06M). SNOA has higher revenues than BNXTF: SNOA (14.9M) vs BNXTF (21.7K).
BNXTFSNOABNXTF / SNOA
Capitalization75.5M6.67M1,132%
EBITDA-4.93M-3.5M141%
Gain YTD151.84650.929298%
P/E RatioN/AN/A-
Revenue21.7K14.9M0%
Total Cash4.24K3.61M0%
Total Debt7.06M675K1,047%
FUNDAMENTALS RATINGS
BNXTF vs SNOA: Fundamental Ratings
BNXTF
SNOA
OUTLOOK RATING
1..100
8651
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3643
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNOA's Valuation (64) in the Pharmaceuticals Other industry is in the same range as BNXTF (77) in the null industry. This means that SNOA’s stock grew similarly to BNXTF’s over the last 12 months.

SNOA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as BNXTF (100) in the null industry. This means that SNOA’s stock grew similarly to BNXTF’s over the last 12 months.

SNOA's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as BNXTF (100) in the null industry. This means that SNOA’s stock grew similarly to BNXTF’s over the last 12 months.

BNXTF's Price Growth Rating (36) in the null industry is in the same range as SNOA (43) in the Pharmaceuticals Other industry. This means that BNXTF’s stock grew similarly to SNOA’s over the last 12 months.

SNOA's P/E Growth Rating (52) in the Pharmaceuticals Other industry is somewhat better than the same rating for BNXTF (100) in the null industry. This means that SNOA’s stock grew somewhat faster than BNXTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNXTFSNOA
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSADF23.44N/A
N/A
MS&AD Insurance Group Holdings, Inc.
NWKHY7.17N/A
N/A
Netcare, Ltd.
PNXPF0.03N/A
N/A
Planet Ventures Inc
HSHZY9.48N/A
N/A
Hoshizaki Corporation
ABMBF0.07-0.01
-7.66%
Abcourt Mines Inc.

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
N/A
TAK - BNXTF
32%
Poorly correlated
-2.07%
SNOA - BNXTF
29%
Poorly correlated
-0.49%
SDZXF - BNXTF
29%
Poorly correlated
N/A
ALVO - BNXTF
13%
Poorly correlated
-5.36%
ESAIY - BNXTF
11%
Poorly correlated
-2.50%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-0.49%
BNXTF - SNOA
29%
Poorly correlated
N/A
BGLAF - SNOA
27%
Poorly correlated
N/A
AKAN - SNOA
25%
Poorly correlated
-11.96%
CRDL - SNOA
24%
Poorly correlated
-0.92%
CGC - SNOA
24%
Poorly correlated
-3.52%
More